The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
7 March 2025
No Comments
‘- New High-Speed Filling Line to Support Growing Demand for Sterile Injectables and Strengthen Domestic Supply Chain
– Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT Week 2025
